Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (The AcT Trial)

(23:37)

Who will benefit the most from tenecteplase for intravenous thrombolysis?

(56)

Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (The AcT Trial)

(23:37)

New data supports use of tenecteplase versus alteplase

(1:45)

Should tenecteplase be routinely used for thrombolysis in acute ischemic stroke?

(3:58)

Thrombectomy alone versus with prior tenecteplase: what do we know?

(1:31)

ESO Expedited Recommendation on Tenecteplase for Acute Ischaemic Stroke

(15:44)

TRACE II results: tenecteplase versus alteplase for IVT

(2:5)

Tenecteplase versus alteplase: impact of time to thrombolysis on clinical outcomes

(6:25)

Tenecteplase versus alteplase in a real-world setting

(5:4)

Alteplase vs tenecteplase in MeVO strokes: results from AcT

(2:47)

Mixing Tenecteplase for Acute Ischemic Stroke

(2:42)

Transitioning from alteplase to tenecteplase for stroke thrombolysis in the UK

(2:38)

It’s Time to Switch to Tenecteplase

(16:11)

Could tenecteplase replace alteplase as a treatment for acute ischemic stroke?

(1:7)

Tenecteplase vs. alteplase in ischemic stroke patients with LVO

(1:50)

ATTEST2: alteplase versus tenecteplase for stroke thrombolysis

(7:49)

Dr. Bijoy Menon: Changing Stroke Care- Results of the Alteplase compared to Tenecteplase (AcT) trial

(2:51)

tPA (Alteplase) Mixing Video

(4:34)

Dr. Katie Lin: Comparison of Alteplase to Tenecteplase and AB’s Transition Plan

(4:22)